Related references
Note: Only part of the references are listed.Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study
F. Patti et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study
Francesco Patti et al.
Therapeutic Advances in Neurological Disorders (2009)
A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple scleroses: Speed matters
Douglas R. Denney et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis
R. S. Prakash et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis
B. I. Glanz et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis:: a 3-year follow-up analysis of the BENEFIT study
Ludwig Kappos et al.
LANCET (2007)
Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial
Steven R. Schwid et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population
Kristin Lester et al.
JOURNAL OF BEHAVIORAL MEDICINE (2007)
Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis
L. Feuillet et al.
MULTIPLE SCLEROSIS (2007)
The Rao's Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population
M. P. Amato et al.
MULTIPLE SCLEROSIS (2006)
Interferons and cognition
X Montalban et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Cognitive impairment and decline in different MS subtypes
Stephan C. J. Huijbregts et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies
MP Amato et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Are there protective treatments for cognitive decline in MS?
MP Amato et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Effects of donepezil on memory and cognition in multiple sclerosis
Christopher Christodoulou et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy
M Caggiula et al.
CLINICAL IMMUNOLOGY (2006)
The association between cognitive impairment and physical disability in multiple sclerosis
SG Lynch et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis
K Biernacki et al.
ARCHIVES OF NEUROLOGY (2005)
Haematological effects of interferon-beta-1a (Rebif((R))) therapy in multiple sclerosis
P Rieckmann et al.
DRUG SAFETY (2004)
Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial
M Filippi et al.
LANCET (2004)
The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis
CG Haase et al.
NEUROIMMUNOMODULATION (2004)
Cognitive dysfunction in multiple sclerosis: a review of recent developments
JA Bobholz et al.
CURRENT OPINION IN NEUROLOGY (2003)
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
T Kuhlmann et al.
BRAIN (2002)
Cognitive dysfunction in multiple sclerosis - Natural history, pathophysiology and management
B Bagert et al.
CNS DRUGS (2002)
Cognitive dysfunction in early-onset multiple sclerosis - A reappraisal after 10 years
MP Amato et al.
ARCHIVES OF NEUROLOGY (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
A comparison of observational studies and randomized, controlled trials.
K Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
